Wile Eyes Inc | |
1217 S Greeley Hwy, Suite B, Cheyenne, WY 82007-3034 | |
(307) 634-3452 | |
(307) 634-6643 |
Full Name | Wile Eyes Inc |
---|---|
Type | Facility |
Speciality | Technician/technologist - Optician |
Location | 1217 S Greeley Hwy, Cheyenne, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053495457 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Wile Eyes Inc 1217 S Greeley Hwy, Suite B, Cheyenne, WY 82007-3034 Ph: (307) 634-3452 | Wile Eyes Inc 1217 S Greeley Hwy, Suite B, Cheyenne, WY 82007-3034 Ph: (307) 634-3452 |
News Archive
Mathematical models have become invaluable decision-making tools for public health officials. As demonstrated during the United Kingdom's foot-and-mouth epidemic of 2001, models can be useful in two ways: they can reveal the underlying characteristics of an infection and they can allow the comparison of alternative control measures.
A research group led by Dr. A. Claudio Cuello of McGill University's Faculty of Medicine, Dept. of Pharmacology and Therapeutics, has uncovered a critical process in understanding the degeneration of brain cells sensitive to Alzheimer's disease.
Delineation of the origin of the retrovirus known as XMRV from the genomes of laboratory mice indicates that the virus is unlikely to be responsible for either prostate cancer or chronic fatigue syndrome in humans, as has been widely published.
Mobius Therapeutics, LLC ™ has been awarded a research grant from the National Institute on Deafness and other Communication Disorders (NIDCD) to study its investigational procedure, selective Photodynamic Myringotomy (PDM).
The National Association of Pharmacy Regulatory Authorities (NAPRA) has issued a directive to the provinces requesting that pharmacists not sell Natural Health Products (NHPs) without a Drug Identification Number (DIN), Natural Product Number (NPN) or Drug Identification Number for Homeopathic Medicine (DIN-HM). NAPRA did not engage in consultations with industry participants who will be adversely affected by this move.
› Verified 9 days ago